1. Home
  2. REGN

as 06-18-2024 9:30am EST

$
-
,
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in immunology; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and CRISPR-based gene editing (Intellia).

Founded: 1988 Country:
United States
United States
Employees: N/A City: TARRYTOWN
Market Cap: 108.0B IPO Year: 1991
Target Price: $994.56 AVG Volume (30 days): 388.6K
Analyst Decision: Buy Number of Analysts: 25
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 33.86 EPS Growth: -7.96
52 Week Low/High: $684.81 - $1052.34 Next Earning Date: 08-01-2024
Revenue: $13,100,100,000 Revenue Growth: 5.90%
Revenue Growth (this year): 7.52% Revenue Growth (next year): 8.16%

REGN Daily Stock ML Predictions

Stock Insider Trading Activity of Regeneron Pharmaceuticals Inc. (REGN)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $979.40 2 $1,958.80 18,080 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $980.16 3 $2,940.48 18,077 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $981.95 3 $2,945.85 18,074 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $982.99 1 $982.99 18,073 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $984.52 2 $1,969.04 18,071 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $988.66 2 $1,977.32 18,069 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $990.74 4 $3,962.96 18,065 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $992.19 7 $6,945.33 18,058 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $993.20 12 $11,918.40 18,046 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $994.25 5 $4,971.25 18,041 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $995.76 6 $5,974.56 18,035 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $996.83 12 $11,961.96 18,023 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $997.76 15 $14,966.40 18,008 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $998.44 14 $13,978.16 17,994 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $999.43 7 $6,996.01 17,987 SEC Form 4
RYAN ARTHUR F REGN Director Jun 3 '24 Sell $1,000.04 5 $5,000.20 17,982 SEC Form 4
BROWN MICHAEL S REGN Director May 28 '24 Sell $974.86 1,172 $1,142,535.92 1,382 SEC Form 4
LAROSA JOSEPH J REGN EVP General Counsel and Secret May 21 '24 Sell $994.90 1,865 $1,855,488.50 34,678 SEC Form 4
SCHLEIFER LEONARD S REGN Bd. Co-Chair, President & CEO May 17 '24 Sell $979.22 22,687 $22,215,564.14 467,020 SEC Form 4
SCHLEIFER LEONARD S REGN Bd. Co-Chair, President & CEO May 17 '24 Sell $980.07 143 $140,150.01 466,877 SEC Form 4
YANCOPOULOS GEORGE REGN Bd. Co-Chair, President & CSO May 16 '24 Sell $967.40 907 $877,431.80 835,476 SEC Form 4
YANCOPOULOS GEORGE REGN Bd. Co-Chair, President & CSO May 16 '24 Sell $968.44 3,213 $3,111,597.72 832,263 SEC Form 4
YANCOPOULOS GEORGE REGN Bd. Co-Chair, President & CSO May 16 '24 Sell $969.39 9,501 $9,210,174.39 822,762 SEC Form 4
YANCOPOULOS GEORGE REGN Bd. Co-Chair, President & CSO May 16 '24 Sell $970.26 4,669 $4,530,143.94 818,093 SEC Form 4
YANCOPOULOS GEORGE REGN Bd. Co-Chair, President & CSO May 16 '24 Sell $971.56 4,922 $4,782,018.32 813,171 SEC Form 4

Share on Social Networks: